Coronavirus Vaccine Doses
- All
- News
- Videos
-
Supreme Court Agrees To Hear Plea Over Covishield Side-Effect Concern
The Supreme Court will hear a petition on a rare side-effect associated with the COVID vaccine developed jointly by British pharma giant AstraZeneca and Oxford University, manufactured by the Serum Institute of India and sold in India as Covishield.
-
Odisha Requests Centre For 50,000 Vaccines Amid Covid Spike
With more than 100 cases of coronavirus being reported in Odisha for four days now, the state government Tuesday requested the Centre for at least an additional 50,000 doses of vaccine.
-
Jharkhand Seeks 50,000 Covid Vaccine Doses From Centre As Cases Rise
Amid rising cases of coronavirus, Jharkhand Health Minister Banna Gupta urged the Centre to provide at least 50,000 COVID-19 vaccine doses to continue with the immunisation drive in the state.
-
No Need For 4th Dose Of Covid Vaccine Given Current Evidence: Expert
Dr Raman Gangakhedkar, former head of epidemiology and communicable diseases at the Indian Council of Medical Research, has discounted the need for the fourth dose of COVID-19 vaccine given the current evidence about the coronavirus and its variants.
-
Serum Institute Seeks Inclusion Of Covid Jab 'Covovax' In CoWIN Portal
Serum Institute of India has written to the Union Health Ministry seeking the inclusion of its Covid vaccine Covovax in the CoWIN portal as a heterologous booster dose for adults, official sources said on Wednesday.
-
Centre's Panel Recommends Market Clearance To Covovax As Covid Booster: Report
An expert panel of the central drug regulatory authority has recommended market authorisation for Serum Institute of India's Covid vaccine Covovax as a heterologous booster dose for adults, Press Trust of India reported.
-
Administering 220 Crore Doses Of Covid Vaccine In India Highpoint Of 2022
2022 saw a new wave of infections driven by the Omicron variant of coronavirus which ultimately subsided, putting India along with the world on the route to normalcy before fresh concerns arose amid rise in cases globally at the fag end of the year.
-
All Government Centres In Delhi Out Of Free Covid Booster, Shows CoWIN
Those aged 60+ are eligible for free dose at government facilities, while it costs Rs 400 for all age groups at private centres
-
Can't Take Nasal Vaccine After Booster: Covid Task Force Chief To NDTV
India's nasal vaccine cannot be administered to those who have taken a precaution or booster dose, the head of the country's vaccine task force told NDTV today in an exclusive interview.
-
Insurance Regulator Wants Discount For Policyholders With 3 Vaccine Doses
Amid a surge in coronavirus cases in several countries, regulator Irdai has asked insurers to consider giving discount on renewal of general and health insurance policies to policyholders who have taken three shots of COVID-19 vaccine.
-
50 Million Doses Of Covaxin Set To Expire Early 2023: Report
Nearly 50 million doses of Bharat Biotech's COVID-19 vaccine, Covaxin lying with the firm are set to expire early next year as there are no takers owing to poor demand, company sources said.
-
Covid-19: Here's Why You Should Get Covid Booster Shot If You Haven't Already
Coronavirus: For those who have received the COVID-19 vaccine but may not have had a strong enough immune response, a second primary dose is advised.
-
India Logs 21,411 New COVID-19 Cases, 67 Covid Deaths In 24 Hours: Centre
India's COVID-19 tally climbed to 4,38,68,476 today with 21,411 fresh cases, while the number of active cases increased to 1,50,100, according to Union health ministry data.
-
Coronavirus Highlights: Free Covid Booster Dose For All Adults From Today
With an aim to increase the uptake of the precautionary dose of COVID vaccine among the eligible adult population, 75 days - 'COVID Vaccination Amrit Mahotsava' commenced on Friday.
-
Free Covid Booster Doses Will Create "Healthier" Country: PM Modi
Prime Minister Narendra Modi on Wednesday said the government's decision to administer free booster doses of COVID-19 vaccines to all citizens aged above 18 will further India's vaccination coverage and create a healthier country.
-
Supreme Court Agrees To Hear Plea Over Covishield Side-Effect Concern
The Supreme Court will hear a petition on a rare side-effect associated with the COVID vaccine developed jointly by British pharma giant AstraZeneca and Oxford University, manufactured by the Serum Institute of India and sold in India as Covishield.
-
Odisha Requests Centre For 50,000 Vaccines Amid Covid Spike
With more than 100 cases of coronavirus being reported in Odisha for four days now, the state government Tuesday requested the Centre for at least an additional 50,000 doses of vaccine.
-
Jharkhand Seeks 50,000 Covid Vaccine Doses From Centre As Cases Rise
Amid rising cases of coronavirus, Jharkhand Health Minister Banna Gupta urged the Centre to provide at least 50,000 COVID-19 vaccine doses to continue with the immunisation drive in the state.
-
No Need For 4th Dose Of Covid Vaccine Given Current Evidence: Expert
Dr Raman Gangakhedkar, former head of epidemiology and communicable diseases at the Indian Council of Medical Research, has discounted the need for the fourth dose of COVID-19 vaccine given the current evidence about the coronavirus and its variants.
-
Serum Institute Seeks Inclusion Of Covid Jab 'Covovax' In CoWIN Portal
Serum Institute of India has written to the Union Health Ministry seeking the inclusion of its Covid vaccine Covovax in the CoWIN portal as a heterologous booster dose for adults, official sources said on Wednesday.
-
Centre's Panel Recommends Market Clearance To Covovax As Covid Booster: Report
An expert panel of the central drug regulatory authority has recommended market authorisation for Serum Institute of India's Covid vaccine Covovax as a heterologous booster dose for adults, Press Trust of India reported.
-
Administering 220 Crore Doses Of Covid Vaccine In India Highpoint Of 2022
2022 saw a new wave of infections driven by the Omicron variant of coronavirus which ultimately subsided, putting India along with the world on the route to normalcy before fresh concerns arose amid rise in cases globally at the fag end of the year.
-
All Government Centres In Delhi Out Of Free Covid Booster, Shows CoWIN
Those aged 60+ are eligible for free dose at government facilities, while it costs Rs 400 for all age groups at private centres
-
Can't Take Nasal Vaccine After Booster: Covid Task Force Chief To NDTV
India's nasal vaccine cannot be administered to those who have taken a precaution or booster dose, the head of the country's vaccine task force told NDTV today in an exclusive interview.
-
Insurance Regulator Wants Discount For Policyholders With 3 Vaccine Doses
Amid a surge in coronavirus cases in several countries, regulator Irdai has asked insurers to consider giving discount on renewal of general and health insurance policies to policyholders who have taken three shots of COVID-19 vaccine.
-
50 Million Doses Of Covaxin Set To Expire Early 2023: Report
Nearly 50 million doses of Bharat Biotech's COVID-19 vaccine, Covaxin lying with the firm are set to expire early next year as there are no takers owing to poor demand, company sources said.
-
Covid-19: Here's Why You Should Get Covid Booster Shot If You Haven't Already
Coronavirus: For those who have received the COVID-19 vaccine but may not have had a strong enough immune response, a second primary dose is advised.
-
India Logs 21,411 New COVID-19 Cases, 67 Covid Deaths In 24 Hours: Centre
India's COVID-19 tally climbed to 4,38,68,476 today with 21,411 fresh cases, while the number of active cases increased to 1,50,100, according to Union health ministry data.
-
Coronavirus Highlights: Free Covid Booster Dose For All Adults From Today
With an aim to increase the uptake of the precautionary dose of COVID vaccine among the eligible adult population, 75 days - 'COVID Vaccination Amrit Mahotsava' commenced on Friday.
-
Free Covid Booster Doses Will Create "Healthier" Country: PM Modi
Prime Minister Narendra Modi on Wednesday said the government's decision to administer free booster doses of COVID-19 vaccines to all citizens aged above 18 will further India's vaccination coverage and create a healthier country.
